37 results
8-K
NMRA
Neumora Therapeutics Inc.
14 Jun 24
Submission of Matters to a Vote of Security Holders
4:01pm
of the selection by the audit committee of the board of directors of the Company of Ernst & Young LLP as the independent registered public accounting firm
DEFA14A
zqo2tk y2790sp
25 Apr 24
Additional proxy soliciting materials
4:15pm
DEF 14A
zo1z56j34n
25 Apr 24
Definitive proxy
4:05pm
10-K
jd9pacp ci2h13u
7 Mar 24
Annual report
4:05pm
10-K
EX-31.1
odmx7h3yfuav 63mef6
7 Mar 24
Annual report
4:05pm
10-K
EX-31.2
w011b69bxj
7 Mar 24
Annual report
4:05pm
10-Q
EX-31.1
klkltado
1 Nov 23
Quarterly report
4:05pm
10-Q
t74ce8 f4u
1 Nov 23
Quarterly report
4:05pm
10-Q
EX-31.2
enr90mm0q28z
1 Nov 23
Quarterly report
4:05pm
424B4
so57lb
18 Sep 23
Prospectus supplement with pricing info
4:12pm
S-1/A
rsy 1figqem6
11 Sep 23
IPO registration (amended)
6:07am
S-1/A
EX-10.21
l608594kztmg8sdybc
11 Sep 23
IPO registration (amended)
6:07am
S-1/A
EX-1.1
wej833xh
11 Sep 23
IPO registration (amended)
6:07am
S-1
EX-10.14
2x6ppi sw513fjsil9
25 Aug 23
IPO registration
5:03pm
S-1
EX-2.1
5utb7sguhdgwc8
25 Aug 23
IPO registration
5:03pm
S-1
EX-10.12
cc13j8 foh8cv5f
25 Aug 23
IPO registration
5:03pm